A clinical trial to study the effects of mifepristone and misoprostol given at same time for abortion.

Efficacy of misoprostol administration simultaneously with mifepristone for termination of pregnancy

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

CTRI

Registry ID

CTRI/2010/091/001422

Enrollment

100

Registered

2010-12-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Medical abortion in less than 10 weeks of pregnancy

Interventions

Intervention1: concurrent administration of mifepristone and misoprostol: Mifepristone 200mg per oral and concurrently 400mcg Misoprostol per vaginal Control Intervention1: At 48 hours interval Mifepr

Eligibility

Inclusion criteria

Inclusion criteria: Prescence of intrauterine pregnancy Gestational age not exceeding 63 days at administration of Mifepristone Aged >16 yrs Willingness to comply with schedule of follow up visits

Exclusion criteria

Exclusion criteria: Ectopic Pregnancy Systemic corticosteroid therapy Adrenal sufficiency Asthma Glaucoma Poorly controlled seizures Hb <10 gm% Coagulopathy Anticoagulant therapy Pregnancy with intrauterine device in situ

Design outcomes

Primary

Measure	Time frame
Success of Medical abortionTimepoint: 14 days	—

Secondary

Measure	Time frame
Compare the efficacy of concurrent protocol with 48 hours protocolTimepoint: 14 days	—

Countries

India

Contacts

Public ContactManju Lata Verma

gaganmlv@gmail.com9721250092

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 28, 2026